- 7
- 1 658
Forma Therapeutics
เข้าร่วมเมื่อ 2 พ.ค. 2017
Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit.
We aim to create futures for patients, their families and our employees.
Read our community guidelines: www.formatherapeutics.com/community-guidelines/
We aim to create futures for patients, their families and our employees.
Read our community guidelines: www.formatherapeutics.com/community-guidelines/
Sickle Cell Journeys: Fragrant's Story
Fragrant shares his experience living with sickle cell disease.
มุมมอง: 54
วีดีโอ
Sickle Cell Journeys: Kathereen's Story
มุมมอง 1192 ปีที่แล้ว
Kathereen shares her experience and that of her daughter Candice, who is living with sickle cell disease.
Sickle Cell Journeys: The Madus' Story
มุมมอง 3334 ปีที่แล้ว
Pamela and Emmanuel Madu share their experience and that of their daughter Elechi.
Sickle Cell Journeys: Tabatha's Story
มุมมอง 4784 ปีที่แล้ว
Tabatha is a patient and sickle cell warrior.
Sickle Cell Journeys: Shelfina's Story
มุมมอง 3324 ปีที่แล้ว
Shelfina is an advocate and sickle cell widow.
FORMA Therapeutics - A Culture of Care
มุมมอง 1966 ปีที่แล้ว
A Culture of caring, collaboration, scientific challenge & fun - learn more about why employees choose to work and thrive at FORMA Therapeutics. FORMA is dedicated to making an innovative impact across the drug discovery and development landscape for Cancer and other rare diseases.
The FORMA Therapeutics Difference
มุมมอง 1476 ปีที่แล้ว
What makes FORMA unique? Learn how we are accelerating the creation of life-changing medicines for people with cancer and other serious diseases by leveraging a uniquely productive and collaborative culture across a global network of partners.